- Other Post Graduate Training - Duke University Medical Center (2006-2009)
- Fellowship - Duke University Medical Center (2008-2009), Interventional Cardiology
- Fellowship - Duke University Medical Center (2004-2008), Cardiology
- Residency - Duke University Medical Center (2001-2004), Internal Medicine
- Medical School - University of California, San Francisco (1997-2001)
Aslan Turer, M.D.
- Internal Medicine - Cardiology
- Percutaneous Coronary Interventions (PCI)
- General Cardiology
Aslan Turer, M.D., M.H.S., an Assistant Professor in the Department of Internal Medicine’s Division of Cardiology at UT Southwestern Medical Center, is an interventional and general cardiologist with special expertise in evaluating and treating patients with inherited forms of cardiovascular disease – particularly hypertrophic cardiomyopathy (HCM). He also leads a clinic at UT Southwestern dedicated to genetically screening for, counseling patients about, and treating those conditions.
Dr. Turer earned his medical degree at the University of California, San Francisco School of Medicine. He completed an internal medicine residency, a cardiology fellowship, and a coronary and structural interventional cardiology fellowship at Duke University Medical Center, where he also conducted postdoctoral research.
He also holds a Master of Health Sciences degree from Duke University and a bachelor’s degree in biology from the University of California, Los Angeles.
Dr. Turer is board certified in internal medicine, interventional cardiology, and cardiovascular disease.
A Fellow of both the American College of Cardiology (ACC) and American Heart Association (AHA), Dr. Turer is a member of professional organizations that include Phi Beta Kappa Honor Medical Society, the American Association for the Advancement of Science, and The Endocrine Society.
He also chairs UT Southwestern’s Pharmacy and Therapeutics Committee and serves on the AHA’s Council of Clinical Cardiology, the Council of Functional Genomics and Translational Biology, and Mission Lifeline North Texas STEMI Program.
Dr. Turer’s research interests include risk factors for coronary atherosclerosis, novel biomarkers in cardiac ischemia, and physiological factors in heart failure.
He has published more than 30 journal articles and contributed to the book Post-operative Care of the Valvular Heart Disease Patient.
He and wife Christy Boling Turer, M.D., M.H.S., have two sons.
Meet Dr. Turer
As an interventional cardiologist, Aslan Turer, M.D., M.H.S., takes a different approach to evaluating and treating patients with familial types of heart disease – particularly hypertrophic cardiomyopathy (HCM), a condition that affects about one in 500 people.
While many physicians focus on only the symptoms or genetics, Dr. Turer opts for a more comprehensive approach that includes risk assessment, genetic counseling, and symptom management.
“This integrated approach leads to a very personalized plan of care,” he says.
Dr. Turer is helping UT Southwestern Medical Center – an internationally recognized leader in genetics – translate these advancements to the treatment and research of inherited forms of cardiovascular disease. Thanks largely to his efforts, UT Southwestern has opened the region’s only clinic dedicated to both cardiovascular genetics and patient management.
The cardiovascular genetics clinic treats patients with conditions that include hypertrophic cardiomyopathy, dilated cardiomyopathy, left ventricular non-compaction, Marfan syndrome and related disorders, and familial restrictive cardiomyopathies. It offers genetic screening and counseling for these conditions, as well as for congenital electrical disorders such as Long QT syndrome.
"Some patients come in for genetic screening, while others may have known cardiovascular conditions that are being well-managed by their established physicians,” Dr. Turer says. "However, some of these conditions are uncommon enough that both patients and cardiologists feel more comfortable having longitudinal care at a dedicated clinic."
In addition to benefiting patients, the clinic helps UT Southwestern learn more about and better manage these cardiovascular conditions.
Dr. Turer is board certified in internal medicine, interventional cardiology, and cardiovascular disease. He also sees patients for conditions such as coronary artery disease, angina, and myocardial infarction (heart attack) and performs, as needed, coronary stenting and other interventional cardiac procedures.
- American College of Cardiology (2004)
- American Heart Association- Council of Clinical Cardiology (2005)
- American Heart Association- Council of Functional Genomics and Translational Biology (2012)
- AHA Laennec Young Clinician Award Finalist 2005
- Society of Cardiovascular Angiography and Intervention/Cordis Fellowship Program Grant 2008
- American College of Cardiology Young Investigator Award- 2nd Place 2008
- L. David Hillis Teaching Award 2011
Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O'Connor CM The American journal of cardiology 2010 Jun 105 12 1794-7
Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy.
Turer AT, Samad Z, Valente AM, Parker MA, Hayes B, Kim RJ, Kisslo J, Wang A European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2011 Feb 12 2 131-9
Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the dallas heart study.
Turer AT, Browning JD, Ayers CR, Das SR, Khera A, Vega GL, Grundy SM, Scherer PE The Journal of clinical endocrinology and metabolism 2012 Jun 97 6 E982-6
Understanding the Transition to Acute Illness: The Promise of Perioperative Genomics.
Turer AT, Schwinn DA J Cardiovasc Transl Res 2008 1(12) 171-173
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
Turer AT, Hill JA The American journal of cardiology 2010 Aug 106 3 360-8
Energetics and metabolism in the failing heart: important but poorly understood.
Turer AT, Malloy CR, Newgard CB, Podgoreanu MV Current opinion in clinical nutrition and metabolic care 2010 Jul 13 4 458-65
Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study.
Turer AT, Addo TA, Martin JL, Sabatine MS, Lewis GD, Gerszten RE, Keeley EC, Cigarroa JE, Lange RA, Hillis LD, de Lemos JA Journal of the American College of Cardiology 2011 Jun 57 24 2398-405
Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy.
Huff CM, Turer AT, Wang A Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012 Apr
Adiponectin: mechanistic insights and clinical implications.
Turer AT, Scherer PE Diabetologia 2012 Jun
Publication or presentation of results from multicenter clinical trials: evidence from an academic medical center.
Turer AT, Mahaffey KW, Compton KL, Califf RM, Schulman KA Am Heart J. April 2007 153(4) 674-80
Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion.
Turer AT, Stevens RD, Bain JR, Muehlbauer MJ, van der Westhuizen J, Mathew JP, Schwinn DA, Glower DD, Newgard CB, Podgoreanu MV. Circulation April 2009 119(13) 1736-46
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction.
Turer AT, Mahaffey KW, Gallup D, Weaver WD, Christenson RH, Every NR, Ohman EM. Curr Control Trials Cardiovas Med. August 2005 23 6-12
Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease.
Turer AT, Mahaffey KW, Honeycutt E, Tuttle RH, Shaw LK, Sketch MH Jr, Smith PK, Califf RM, Alexander JH. J Thorac Cardiovasc Surg June 2009 137(6) 1468-74
Cardiology and the critical care crisis: a perspective.
Katz JN, Turer AT, Becker RC J Am. Coll Cardiol. March 2007 49(12) 1279-82
Device therapy in the management of congestive heart failure
Turer AT, Rao SV Cardiol Rev. May 2005 13(3) 130-8
- Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
- Percutaneous Coronary Interventions (PCI)
- General Cardiology
- Diagnostic Cardiac Catheterization